These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4530304)

  • 1. Reversible "transformation" of bromodeoxyuridine-dependent cells by bromodeoxyuridine.
    Davidson RL; Horn D
    Proc Natl Acad Sci U S A; 1974 Sep; 71(9):3338-42. PubMed ID: 4530304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Requirement of bromodeoxyuridine for the maintenance of "transformed" characteristics in bromodeoxyuridine dependent cells.
    Horn D; Davidson RL
    J Cell Physiol; 1975 Apr; 85(2 Pt 1):251-60. PubMed ID: 164475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bromodeoxyuridine dependence--a new mutation in mammalian cells.
    Davidson RL; Bick MD
    Proc Natl Acad Sci U S A; 1973 Jan; 70(1):138-42. PubMed ID: 4509645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of biological effects of bromodeoxyuridine by deoxycytidine: correlation with decreased incorporation of bromodeoxyuridine into DNA.
    Horn D; Davidson RL
    Somatic Cell Genet; 1976 Sep; 2(5):469-81. PubMed ID: 1027154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total substitution of bromodeoxyuridine for thymidine in the DNA of a bromodeoxyuridine-dependent cell line.
    Bick MD; Davidson RL
    Proc Natl Acad Sci U S A; 1974 May; 71(5):2082-6. PubMed ID: 4525473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissociation of plasminogen activator from the transformed phenotype in a 5-bromodeoxyuridine dependent mutant of Syrian hamster melanoma cells.
    Rosenthal SL; Zucker D; Davidson RL
    J Cell Physiol; 1978 Jun; 95(3):275-85. PubMed ID: 649664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel phenotypes arising from selection of hamster melanoma cells for resistance to BUdR.
    Kaufman ER; Davidson RL
    Exp Cell Res; 1977 Jun; 107(1):15-24. PubMed ID: 558895
    [No Abstract]   [Full Text] [Related]  

  • 8. Investigations of the mechanism of decreased tumorigenicity of cells grown in BrdU.
    Rothschild H; Black PH
    J Cell Physiol; 1973 Apr; 81(2):217-24. PubMed ID: 4348555
    [No Abstract]   [Full Text] [Related]  

  • 9. Differences in the incorporation of bromodeoxyuridine by human lymphoblastoid cell lines.
    Henderson EE; Strauss B
    Cell; 1975 Aug; 5(4):381-7. PubMed ID: 1157096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological and biochemical effects of bromodeoxyuridine and deoxycytidine on Syrian hamster melanoma cells.
    Kaufman ER; Davidson RL
    Somatic Cell Genet; 1978 Sep; 4(5):587-601. PubMed ID: 694730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of SV40 T antigen in transformed hamster cells by chronic treatment with 5-bromo-2-deoxyuridine.
    Kreider JW; Del Villano B; Shoff WH; Davidson EA
    Cancer Res; 1972 Oct; 32(10):2148-55. PubMed ID: 4343009
    [No Abstract]   [Full Text] [Related]  

  • 12. A contact-insensitive subpopulation in Syrian hamster cell cultures with a greater susceptibility to chemically induced neoplastic transformation.
    Nakano S; Ueo H; Bruce SA; Ts'o PO
    Proc Natl Acad Sci U S A; 1985 Aug; 82(15):5005-9. PubMed ID: 3860840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a 3T3-like line from an embryo culture of an inbred strain of Syrian golden hamster.
    Kuroki T; Miyashita SY; Yuasa Y
    Cancer Res; 1975 Jul; 35(7):1819-25. PubMed ID: 165885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contact inhibitory factor also restores anchorage and serum dependence to hamster melanoma cells.
    Lipkin G; Rosenberg M; Klaus-Kovtun V
    J Invest Dermatol; 1986 Sep; 87(3):305-8. PubMed ID: 3734481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Bromodeoxyuridine-tolerant melanoma cells in vitro and in vivo.
    Pasztor LM; Hu F; McNulty WP
    Yale J Biol Med; 1973 Dec; 46(5):397-410. PubMed ID: 4544338
    [No Abstract]   [Full Text] [Related]  

  • 16. The kinetics of contact inhibition in mammalian cells.
    Schmialek P; Geyer A; Miosga V; Nündel M; Zapf B
    Cell Tissue Kinet; 1977 Mar; 10(2):195-202. PubMed ID: 558054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bromodeoxyuridine-induced changes in the transformed phenotype.
    Avdalovic N
    Ann N Y Acad Sci; 1980; 349():346-56. PubMed ID: 6939365
    [No Abstract]   [Full Text] [Related]  

  • 18. A potent inhibitor of normal and transformed cell growth derived from contact-inhibited cells.
    Lipkin G; Knecht ME; Rosenberg M
    Cancer Res; 1978 Mar; 38(3):635-43. PubMed ID: 626968
    [No Abstract]   [Full Text] [Related]  

  • 19. Requirement of long progression time for the expression of neoplastic phenotypes following direct perturbation to specific region(s) of DNA of Syrian hamster embryo cells.
    Tsutsui T; Ts'o PO
    Cancer Res; 1986 Jul; 46(7):3533-7. PubMed ID: 3708584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA synthesis and transformation induced in density-inhibited cultures of hamster embryo cells by the carcinogen benzo(alpha)pyrene.
    Mironescu S; Love R
    Cancer Res; 1974 Oct; 34(10):2562-70. PubMed ID: 4472076
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.